Logopharm initiates software development for mass spectrometry
- Details
To meet the increasing needs in bioinformatic processing of mass spectrometry data and to make full use of our proteomic capabilities, the company has decided to focus R&D efforts on development of novel tools for quantification and database integration. The new quantification software shall overcome current limitations of available tools and deliver reliable label-free protein quantification with high sensitivity and over a broad dynamic range. In a first step, it is planned to build a stand-alone version for evaluation of LC-MS/MS data from linear ion trap instruments. It will subsequently be developed into a commercial product and used to build up a proprietary membrane protein interaction database.